ASSOCIATION BETWEEN DURATION OF DIABETES AND SEVERITY OF DIABETIC RETINOPATHY IN A CENTRAL INDIAN POPULATION
Main Article Content
Keywords
Diabetic retinopathy, diabetes duration, non-proliferative diabetic retinopathy, proliferative diabetic retinopathy, Central India, microvascular complications
Abstract
Background: Diabetic retinopathy (DR) is one of the leading causes of preventable blindness and visual impairment in adults around the world due to the rising prevalence of type 2 diabetes mellitus (T2DM). The duration of diabetes is a known, non-modifiable risk factor for the development of microvascular complications. However, there is a dire need for regional epidemiological data mapping that associates the exact duration of diabetes with the graded severity of DR. This will help in designing localised public health and screening policies. The aim of this study was to evaluate the relationship between duration of diabetes and severity of diabetic retinopathy in a unique population of Central India.
Methods: A hospital-based, cross-sectional, observational study was conducted for a period of six months c at a tertiary care center in Central India. The study enrolled 75 adult patients with previously diagnosed type 2 diabetes mellitus (T2DM). Dilated ophthalmic examinations included slit-lamp biomicroscopy and binocular indirect ophthalmoscopy. Diabetic retinopathy was graded according to Early Treatment Diabetic Retinopathy Study (ETDRS) classification criteria. The obtained data such as age, sex, duration of diabetes, glycaemic control and systemic comorbidities were subjected to statistical analysis using descriptive statistics, Chi-square test and correlational analyses.
Results: Overall prevalence of DR was 58.7% (n=44) of 75 subjects evaluated. A statistically significant positive correlation was found between the duration of diabetes and the severity of DR. The prevalence of DR was low (22.2%) in patients with <5 years of diabetes duration and was characterised mainly by mild non-proliferative changes. Conversely, 91.7% of patients with diabetes for more than 15 years had retinal complications and severe NPDR and PDR were found in 41.7% of this group within this time. Synergistic effects on severity were observed for other variables, e.g., coexisting hypertension and increased HbA1c levels.
Conclusion: Chronicity of diabetes mellitus is the major determinant of the onset and progressive severity of diabetic retinopathy in Central Indian population. The exponential rise in vision threatening DR after a decade of disease duration emphasises the critical need for rigorous annual retinal screening in a protocol driven manner for all diabetic patients to detect early and intervene timely to prevent irreversible ocular morbidity.
References
2.Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556-564. (Included for historical benchmark context in text)
3.Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. The Lancet Diabetes & Endocrinology. 2017;5(8):585-596.
4.Vashist P, Singh S, Gupta N, Saxena R. Role of early screening for diabetic retinopathy in patients with diabetes mellitus: an overview. Indian J Community Med. 2011;36(4):247-252. doi:10.4103/0970-0218.91324.
5.Wang W, Lo ACY. Diabetic Retinopathy: Pathophysiology and Treatments. International Journal of Molecular Sciences. 2018;19(6):1816.
6.Kang Q, Yang C. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biology. 2020;37:101799.
7.Whitehead M, Wickremasinghe S, Osborne A, Van Wijngaarden P, Martin KR. Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies. Expert Opin Biol Ther. 2018 Dec;18(12):1257-1270. doi: 10.1080/14712598.2018.1545836.
8.Song P, Yu J, Chan KY, Theodoratou E, Rudan I. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. Journal of Global Health. 2018;8(1):010803.
9.Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44(2):156-163.
10.Cheloni R, Gandolfi SA, Signorelli C, Odone A. Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis. BMJ Open. 2019;9(3):e022188.
11.Wu L, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M. Classification of diabetic retinopathy and diabetic macular edema. World Journal of Diabetes. 2013;4(6):290-294. (Standard ETDRS methodology reference)
12.Raman R, Rani PK, Reddi Rachepalle S, Gnanamoorthy P, Uthra S, Kumaramanickavel G, et al. Prevalence of Diabetic Retinopathy in India. Ophthalmology. 2009;116(2):311-318.
13.Brar AS, Sahoo J, Behera UC, Jonas JB, Sivaprasad S, Das T. Prevalence of diabetic retinopathy in urban and rural India: A systematic review and meta-analysis. Indian Journal of Ophthalmology. 2022;70(6):1945-1955.
14.Gadkari SS, Maskati QB, Nayak BK. Prevalence of diabetic retinopathy in India: The All India Ophthalmological Society Diabetic Retinopathy Eye Screening Study 2014. Indian Journal of Ophthalmology. 2017;65(3):191-197.
15.Gelcho GN, Gari FS. Time to diabetic retinopathy and its risk factors among diabetes mellitus patients in Jimma University Medical Center, Jimma, Southwest Ethiopia. Ethiop J Health Sci. 2022;32(5):937-946. doi:10.4314/ejhs.v32i5.9.
16.Jha A, Verma A, Alagorie AR. Association of severity of diabetic retinopathy with corneal endothelial and thickness changes in patients with diabetes mellitus. Eye (Lond). 2022;36(6):1202-1208. doi:10.1038/s41433-021-01606-x.
17.Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. New England Journal of Medicine. 2012;366(13):1227-1239. (Crucial pathophysiology benchmark)
18.Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins A, et al. The progress in understanding and treatment of diabetic retinopathy. Progress in Retinal and Eye Research. 2016;51:156-186. (Review of neovascular progression)
19.Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive retinopathy revisited: some answers, more questions. British Journal of Ophthalmology. 2018;102(8):1024-1025.
20.Lind M, Pivodic A, Svensson AM, Ólafsdóttir AF, Wedel H, Ludvigsson J. HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study. BMJ. 2019;366:l4894.

